[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370178-105":59,"doc-detail-370178-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","harnessing-the-tumor-microenvironment-targeted-cancer-therapies-through-modulation-of-epithelial-mesenchymal-transition","Harnessing the tumor microenvironment - targeted cancer therapies through modulation of epithelial-mesenchymal transition","","The tumor microenvironment (TME) drives cancer progression by shaping metastasis and treatment response. It includes diverse cell types, extracellular matrix components, and signaling molecules that coordinate tumor growth and therapeutic resistance. A central TME-induced program is epithelial-mesenchymal transition (EMT), where epithelial cells gain mesenchymal traits, increasing motility and invasiveness. This review evaluates how modulating TME components can disrupt TME–EMT interactions, address resistance mechanisms, and outline therapeutic strategies with key limitations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/harnessing-the-tumor-microenvironment-targeted-cancer-therapies-through-modulation-of-epithelial-mesenchymal-transition/370178/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/harnessing-the-tumor-microenvironment-targeted-cancer-therapies-through-modulation-of-epithelial-mesenchymal-transition/370178.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does the tumor microenvironment (TME) play in cancer progression?","Question",{"text":112,"@type":113},"The TME contributes to cancer progression by promoting tumor growth, metastasis, and treatment resistance through interactions among cells, extracellular matrix components, and signaling molecules.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does epithelial-mesenchymal transition (EMT) relate to TME signaling?",{"text":117,"@type":113},"TME signaling can induce EMT, enabling epithelial cells to acquire mesenchymal traits that increase motility and invasiveness and thereby support metastasis and progression.",{"name":119,"@type":110,"acceptedAnswer":120},"How can targeting TME components improve cancer therapy?",{"text":121,"@type":113},"Targeting components of the TME aims to disrupt TME contributions to EMT, improve treatment efficacy, and address therapeutic resistance while also considering practical caveats.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370178,1790238704,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":52,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Glaviano et al.  \nJournal of Hematology & Oncology (2025) 18:6 [https://doi.org/10.1186/s13045-024-01634-6](https://doi.org/10.1186/s13045-024-01634-6)  \nJournal of Hematology & Oncology  \n REVIEW Open Access  \nHarnessing the tumor microenvironment:  \ntargeted cancer therapies through modulation of epithelial-mesenchymal transition  \nAntonino Glaviano1, Hannah Si‑Hui Lau2,3, Lukas M. Carter4, E. Hui Clarissa Lee5,6, Hiu Yan Lam5,6,  \nElena Okina5,6, Donavan Jia Jie Tan5,6,7, Wency Tan5,6,7, Hui Li Ang5,6, Daniela Carbone1, Michelle Yi‑Hui Yee2, Muthu K. Shanmugam5,6, Xiao Zi Huang8, Gautam Sethi5,6, Tuan Zea Tan8, Lina H. K. Lim2,9,10,  \nRuby Yun‑Ju Huang 11,12, Hendrik Ungefroren13, Elisa Giovannetti14,15, Dean G. Tang 16,17, Tullia C. Bruno 18, Peng Luo19, Mads Hald Andersen20, Bin‑Zhi Qian21, Jun Ishihara22, Derek C. Radisky23, Salem Elias24, Saurabh Yadav24, Minah Kim25, Caroline Robert26,27, Patrizia Diana 1, Kurt A. Schalper28, Tao Shi29,  \nTaha Merghoub29,30, Simone Krebs31, Anjali P. Kusumbe32, Matthew S. Davids24, Jennifer R. Brown24 and Alan Prem Kumar5,6*  \nAbstract  \nThe tumor microenvironment (TME) is integral to cancer progression, impacting metastasis and treatment response. It consists of diverse cell types, extracellular matrix components, and signaling molecules that interact to promote tumor growth and therapeutic resistance. Elucidating the intricate interactions between cancer cells and the TMEis crucial in understanding cancer progression and therapeutic challenges. A critical process induced by TME signaling is the epithelial‑mesenchymal transition (EMT), wherein epithelial cells acquire mesenchymal traits, which enhance their motility and invasiveness and promote metastasis and cancer progression. By targeting various componentsoftheTME, novel investigational strategies aim to disrupt the TME’s contribution to the EMT, thereby improving treatment efficacy, addressing therapeutic resistance, and offering a nuanced approach to cancer therapy. This review scrutinizes the key players in theTME and theTME’s contribution to the EMT, emphasizing avenues to thera‑ peutically disrupt the interactions between the various TME components. Moreover, the article discusses the TME’s implications for resistance mechanisms and highlights the current therapeutic strategies toward TME modulation along with potential caveats.  \nKeywords Cancer, Tumor microenvironment (TME), T‑cells, B‑cells, tumor‑associated macrophages(TAMs), Natural killer (NK) cells, Myeloid‑derived suppressor cells (MDSCs), Tumor‑associated neutrophils (TANs), Dendritic cells (DCs), Cancer‑associated fibroblasts (CAFs), Extracellular matrix (ECM), Chimeric antigen‑receptor (CAR) T‑cell therapy, T‑cell receptor (TCR) therapy, Metastasis, Epithelial‑mesenchymal transition (EMT), Theranostics  \n†Antonino Glaviano, Hannah Si‑Hui Lau have equally contributed to this work.  \n*Correspondence: Alan Prem Kumar [apkumar@nus.edu.sg](apkumar@nus.edu.sg)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution‑NonCommercial‑NoDerivatives 4.0 International License, which permits any non‑commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.","cbCairKbyj3JF7UP","https://ap.wps.com/l/cbCairKbyj3JF7UP","pdf",8901388,96,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What role does the tumor microenvironment (TME) play in cancer progression?\",\"answer\":\"The TME contributes to cancer progression by promoting tumor growth, metastasis, and treatment resistance through interactions among cells, extracellular matrix components, and signaling molecules.\"},{\"question\":\"How does epithelial-mesenchymal transition (EMT) relate to TME signaling?\",\"answer\":\"TME signaling can induce EMT, enabling epithelial cells to acquire mesenchymal traits that increase motility and invasiveness and thereby support metastasis and progression.\"},{\"question\":\"How can targeting TME components improve cancer therapy?\",\"answer\":\"Targeting components of the TME aims to disrupt TME contributions to EMT, improve treatment efficacy, and address therapeutic resistance while also considering practical caveats.\"}]","Harnessing the tumor microenvironment - targeted cancer therapies through modulation of epithelial-mesenchymal transition | PDF",1790187172,242,[147,151,155,159,163,167,171,175,179,183],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfd920d81f4c3cc849c35db159e7ef21.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/459b5b984fdb4a46d7e2da00a0f80035.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59b9c632cbcd4ed9888319e1b44aaca7.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c76696088559848af4137caa8826ee56.webp",980,1301,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5dbae84af7b353a2b3dadfb366808bcd.webp",979,1300,{"page_no":29,"url":168,"width":169,"height":170},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa44e9ebeda8dea79baa81c2f727b2e2.webp",978,1299,{"page_no":34,"url":172,"width":173,"height":174},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bec7809cd0c115371d33bf3d83781621.webp",977,1297,{"page_no":39,"url":176,"width":177,"height":178},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd9a5e8f4b0d183219640e205a0ee64c.webp",976,1296,{"page_no":44,"url":180,"width":181,"height":182},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7fa33699ddee4388e6893a22f66b885c.webp",975,1295,{"page_no":52,"url":184,"width":185,"height":186},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfb8294aa3fe0e64622f4623f3b997fd.webp",974,1293]